These symptoms typically emerge during dose initiation or escalation and often diminish over time as the body adjusts to the medication
In the course of the present study, the following inhibitors of glutamate dehydrogenase were identified: epigallocatechin-3-gallate (EGCG), hexachlorophene (HCP), bithionol (BTH), GW5074, CPD-3B, ebselenin, R162, and others(Table 3)
Nature 521 , 489494 (2015)
Feeling stuck, dealing with side effects, or unsure what steps to take next
If the alternating pattern persists or worsens, discuss with your provider whether staying at your current dose longer before increasing might help your digestive system adapt more fully